Sep 2026 · Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 23 Sep - Astral to attend Nuvama Emerging India CEO Forum in Mumbai on 28 September 2026.
Source: Bse
Industrials stocks · Mid cap · NSE
Astral Limited is an Indian manufacturer of plumbing, drainage, and fire protection piping systems. The company has diversified into adhesives, sealants, and paints, emphasizing innovation, backward integration, and expanding its product portfolio and distribution network across these segments.
SMA20 -5.3% / mo · MACD +
Latest mapped FPI equity flow was not positive. View sector evidence
Adjusted completed-session prices, rebased to 100
Weak fundamentals, management evidence is still limited to a financial-only Trust Lite signal, price trend argues for patience, and recent execution is consistent.
Fundamental lens: valuation, quality, growth, balance sheet, and cash flow.
Revenue +15.9% · PAT +51.9% YoY
Price trend and sector-relative-strength timing.
Legacy margin-of-safety estimate; the revised evidence label remains in shadow validation.
Financial-only signal; management claim evidence is not sufficient yet.
Fundamentals, quarterly history, margins, returns and balance-sheet evidence
Rev +16% YoY · PAT +52% YoY · margin expansion · operating leverage
| Metric | This quarter | YoY | QoQ |
|---|---|---|---|
| Revenue | ₹1,578 Cr | +15.9% | -24.4% |
| EBITDA | ₹231 Cr | +24.9% | -39.7% |
| Operating margin | 15.0% | +100 bps | -300 bps |
| PAT | ₹120 Cr | +51.9% | -43.7% |
| PAT margin | 7.6% | +180 bps | -260 bps |
NDF means not disclosed in the current structured filing feed. It is intentionally not treated as zero.
Updated 19/10/2026
Trend interpretation, Stage 2, relative strength, volume and indicator evidence
Trend is weak — long-term trend down. RSI 51.
Mechanical read from the price + indicator series above. Not a recommendation — technical setups can reverse without warning, especially around earnings and macro events.
U-Score 39 · legacy U-Score band WATCHLIST · valuation evidence and comparable companies
Top U-Score contributors and drags from the latest stored fundamentals.
For this sector, IndiaPulse uses a blended lens rather than relying on a single valuation ratio.
This shows the stored score trend when snapshots exist, and also compares the latest stored nightly score with a live recompute from current fundamentals and price.
12 stored score snapshots. Latest stored move: +0 points.
Business-comparable peers in Industrials — ranked by industry, sub-sector, theme-tag overlap, market cap, and U-Score similarity. Green cells mark the best available peer metric in this table.
Growth engines, risks, management commitments and evidence-backed delivery
Management projects strong FY27 value growth for piping (18-25%) driven by polymer price inflation and 8-15% volume growth. Adhesive and paint segments target 15-20% and 25-30% growth respectively, with UK business turning EBITDA positive.
Management is executing on strategic diversification and backward integration, with key projects like CPVC resin manufacturing nearing commissioning. While some segments faced past challenges (UK, Paints), they are now showing signs of recovery and growth. The focus on innovation and distribution expansion supports long-term growth.
Backward integration of CPVC which is going to be a game changer for Astral. Our margins were 12% EBITA. We increased from 12% today to 16 to 18%. Now we are going further backward integration which is more better.
Continuously investing into the R&D and try to see that how best way we can bring new products on to the table. We have more than 56 products. On the bathware side, we are growing at 25-30% sort of CAGAR.
Last year itself we've added 20% more channel partners. Added 300 new distributors last year, 7,000 retailers, 100 plus geographies.
Adhesive is growing at a good pace. The vision is to touch 2000 as fast as we can and we are sure that in next 3 to four years we'll be touching 2000 plus in Indian revenue. Targeting to reach 1,000 crores in next 3 to four years and even cross that for paints.
CPVC R&D started four years back. Machineries have also started arriving in. By December trials will start. Q4 we should be ready for the commercial production. Initial capacity 40,000 metric ton, expandable to one lakh.
PEX line is one of the most advanced lines in India. Machines arrived last week, by September should be up and running. Single line can take care of about 350 to 400 odd crores of top line.
Last year we commissioned the Kanpur plant and the Hyderabad also. This is helping us to gain market share due to proximity to market.
This is the first time after 3 year we are seeing that now there is a regular inflationary trend will start and this year we are expecting at least 10% kind of inflation will be there. This will boost top line.
Bigger players are going to get more and more bigger. Smaller companies are getting butchered in this environment because if the polymer prices are going to go up, there is going to be a big challenge of working capital.
Lot of infrastructure spending announcement government has done, including Jal Jeevan mission and Pradhan Mantri Awas scheme. Budgetary allocation is very high.
Polymer cycle is still we are not expecting to be a stable kind of cycle. Still volatility is going to be there. Till the war kind of situation is not going to be completely settled down.
Challenging the legacy brand is always a big big challenge but we are lucky that we are now getting into the right direction (Paints).
UK had its own issues. Our promoter who was with us cashed out most of it and then there was a bit of mismanagement done.
End of the day it is a chemical plant. So maybe one or two month can be here and there. So safely you can project in your number for the next year full year.
Till the war kind of situation is not going to be completely settled down. We are of the view that polymer is going to be remain on a volatile side and more on the upward side than the downward side.
People will follow Astral. People will do copy for Astral but copy doesn't have a brain. Most of the players have done lot of copy of Astral but there they have miserably failed also.
Issuer guidance and extracted claims are tracked against later reported outcomes. Treat these as management statements, not IndiaPulse forecasts.
YoY is crucial for assessing the impact of strategic shifts, annual growth targets, and the cyclical nature of polymer prices. QoQ is relevant for monitoring the sequential ramp-up of new capacities and the turnaround of specific businesses like UK operations.
Industry should grow somewhere around 8% kind of volume in FY27. FY27 we are expecting that the volume should be in the range of 10 to 15%.
If the volume growth will be 8%, then the value will be 18%. If 15% volume growth comes if 10% bottom even if come then also value growth will be 20%.
Utilization of plant in the last quarter Q4 our capacity is 4 lakh something and we have sold 84000 Matrix almost more than 80% utilization.
Project pipeline is more than 100 crores as of today.
Products that are first in India, relatively low competition, predominantly imported and sold in India, and products that have a good future considering how the Indian construction industry is evolving.
We also are not looking at any other segments now than whatever the four segments we are in. The foundation is ready, platform is ready, now the time has come to scale.
Spending lot of money into the digitalization. More transparency will be there. Giving the fastest credit note to our distributor because we understand that for any distributor the working capital is the key.
M&A side activity will continue. If we get a good opportunity or right opportunity at a right valuation we are always ready to take and grab that opportunity.
| Checkpoint | Current evidence | What to verify next |
|---|---|---|
| CPVC Resin Plant Commercial Production | Trials expected by December, Q4 FY27 commercial production targeted. | Timely commissioning and ramp-up of the 40,000 MT CPVC resin plant, and subsequent expansion to 1 lakh MT. |
| Paints Segment EBITDA Positivity | FY26 saw 23% growth, last quarter 31%. | Achievement of positive EBITDA for the paints business in FY27, alongside 25-30% growth. |
| Adhesive India Revenue Target | India CAGR more than 15% over last decade. | Progress towards the vision of touching 2000 crores in Indian adhesive revenue within the next 3-4 years. |
| UK Business Growth & EBITDA | Last quarter 22.9% growth in bond product, 6.5% positive EBITDA. | Sustained double-digit growth and 8-10% plus EBITDA margin for the UK business in FY27. |
Verification checkpoints are IndiaPulse research interpretation, not investment advice.
Trust asks: does management behaviour match later outcomes? Higher is better, but confidence and evidence depth matter as much as the number.
Limited evidence: Claim history is still being built. It ranks around the 88th percentile of the scored universe and 88th percentile within Industrials. No major sub-score weakness stands out.
This is a financial-behaviour screen, not a claim-tested management reliability verdict.
Financial behaviour is scored, but management claims do not yet have enough outcome checks.
overall median 67 · Industrials: 88th pctile, median 68 · Mid: 67th pctile, median 76
30 documents have extracted text, but claim history is not strong enough yet.
0 claims extracted · No contradicted claim yet
Read Trust alongside U-Score, result consistency, and technical trend. A cheap stock with weak Trust needs a larger margin of safety; a high Trust score does not make an expensive stock attractive by itself.
Read low sub-scores as due-diligence warnings, not automatic sell signals.
Trust Lite uses financial behaviour only. Prefer claim-tested Trust when enough concall claims have later outcomes.
Latest exchange and company disclosures found within the past two years.
Source: Bse
Source: Bse
Source: Company Ir
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse